Detailed answers about UK NUOSENBOLAN BIOLOGY ENGINEERING CO., LIMITED, including incorporation, status, business activity, and accounts information.
When was UK NUOSENBOLAN BIOLOGY ENGINEERING CO., LIMITED founded?
UK NUOSENBOLAN BIOLOGY ENGINEERING CO., LIMITED was officially incorporated on 2 November 2015 and is registered under company number 09852938. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is UK NUOSENBOLAN BIOLOGY ENGINEERING CO., LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of UK NUOSENBOLAN BIOLOGY ENGINEERING CO., LIMITED?
UK NUOSENBOLAN BIOLOGY ENGINEERING CO., LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does UK NUOSENBOLAN BIOLOGY ENGINEERING CO., LIMITED do?
UK NUOSENBOLAN BIOLOGY ENGINEERING CO., LIMITED operates in the following sector: 99999 - Dormant Company. This provides insight into the company's primary business activity and industry focus.
What is UK NUOSENBOLAN BIOLOGY ENGINEERING CO., LIMITED's registered address?
The registered office address of UK NUOSENBOLAN BIOLOGY ENGINEERING CO., LIMITED is 37 CROYDON ROAD, BECKENHAM, UNITED KINGDOM, BR3 4AB. This is the official address filed with Companies House for legal and statutory correspondence.
Is UK NUOSENBOLAN BIOLOGY ENGINEERING CO., LIMITED financially stable?
The most recent accounts for UK NUOSENBOLAN BIOLOGY ENGINEERING CO., LIMITED were made up to 30 November 2025, filed as DORMANT. Next accounts are due by 31 August 2027.